Which has grown faster, ALVO or AXGN?

Over the past five years, ALVO grew revenue faster — ALVO at a 69.03% CAGR versus AXGN at 13.99%.

Alvotech (ALVO) vs AxoGen, Inc. (AXGN)

A side-by-side comparison of Alvotech and AxoGen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ALVO

Alvotech

$2.07B

$6.14HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT

AXGN

AxoGen, Inc.

$1.97B

$36.55HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT

Total return — ALVO vs AXGN

growth of $100 · dividends reinvested · last 4y

ALVO -45.4% (-14.0%/yr)AXGN +351.7% (+45.8%/yr)AXGN compounded faster over this window

Log scale — wide-divergence pair

ALVO AXGN

ALVO vs AXGN: by the numbers

•ALVO is the larger company ($2.07B vs $1.97B market cap).
•Both run net losses; AXGN's is the smaller (-13.36% vs -36.51% net margin).
•ALVO grew revenue faster over the past five years (69.03% vs 13.99% CAGR).

Metrics side by side

Valuation

Metric	ALVO	AXGN
Forward P/E	N/A	82.60
P/S ratio	4.22	7.82
P/B ratio	N/A	7.67
EV / EBITDA	41.95	N/A
FCF yield	N/A	0.13%

Profitability

Metric	ALVO	AXGN
Gross margin	60.45%	74.56%
Operating margin	9.62%	-5.12%
Net margin	-36.51%	-13.36%
ROE	N/A	-13.09%
ROIC	3.61%	-4.68%

Growth (annualized)

Metric	ALVO	AXGN
Revenue CAGR (5Y)	69.03%	13.99%
Total return CAGR (5Y)	N/A	19.40%

Frequently asked

Which has grown faster, ALVO or AXGN?: Over the past five years, ALVO grew revenue faster — ALVO at a 69.03% CAGR versus AXGN at 13.99%.

Go deeper

Full ALVO analysis Full AXGN analysis Interactive comparison tool

Dig into the metrics

Alvotech ROE AxoGen ROE Alvotech operating margin AxoGen operating margin Alvotech revenue growth AxoGen revenue growth Alvotech free cash flow AxoGen free cash flow

Alvotech & AxoGen appear in these rankings

Fastest Revenue Growth Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.